Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

European Innovation Council · Running

SynMech A synaptic mechanogenetic technology to repair brain connectivity

Coordinator
Universita Degli Studi Di Trieste, Italy
Runs
1 February 2023 to 31 January 2028
Status
Running
EU funding
€3.5m
Total cost
€3.5m
Partners
8 organisations in 4 countries
Type
European Innovation Council
Grant agreement
101099579

What the project is doing

In the project's own words, from its summary on CORDIS.

We aim to develop a mechanogenetic technology to regulate functional connectivity of neural circuits, and show how it can be harnessed for therapeutic purposes in high-prevalence treatment-resistant brain disorders. Mechanogenetics is an emerging field of health science that attempts to regulate neural networks by combining the advantages of optogenetics with those of magneto-mechanical stimulations; like optogenetics, it relies on targeted actuators to achieve circuit specificity, while exploiting magnetic fields to remotely stimulate the brain.

Yet, despite solid theoretical foundations and encouraging experimental results, we are to date unable to repair a dysfunctional brain using mechanogenetics due to technological barriers in spatial resolution and in vivo implementation. We propose an innovative solution based on functionalized biocompatible magnetic nanoparticles and bioengineered synaptic mechanosensors that synergistically integrate at specific synaptic connections to bidirectionally regulate brain circuit connectivity in response to focused magnetic fields of different frequencies delivered via high-permeability transcranial magnetic stimulators.

By hijacking the signaling pathways of synaptic mechanosensors, we aim to promote a normalization of neural circuit activity that outlasts the therapeutic intervention. We will assess the capacity of the synaptic mechanogenetic toolkit to promote and depress network activity in mouse models of stroke and epilepsy. To achieve this ambitious goal, we have gathered an interdisciplinary consortium going from material scientists and electronic experts to physiologists and clinicians.

Our approach, based on magnetic fields that penetrate brain tissue unimpeded, is predicted to go beyond current therapeutic paradigms because it does not require implantation of invasive devices, and at the same time, promises to achieve subcellular resolution for repairing connectivity defects that underlie most brain disorders.

Topics

Who is involved

OrganisationCityCountryRole
Universita Degli Studi Di TriesteTriesteItalyCoordinator
Deutsches Zentrum Fur Neurodegenerative Erkrankungen eVBonnGermanyParticipant
Forschungszentrum Julich GmbHJulichGermanyParticipant
Biotalentum Tudasfejleszto KftGoedoelloHungaryParticipant
Consiglio Nazionale Delle RicercheRomaItalyParticipant
Universita Degli Studi Di VeronaVeronaItalyParticipant
Brain Science Tools B.v.De BiltNetherlandsParticipant
Universitair Medisch Centrum UtrechtUtrechtNetherlandsParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI